CJC-1295 No DAC 5mg + Ipamorelin 5mg Blend for Sale | 99% Pure GH Secretagogue Stack

Give a pituitary cell one signal and it responds. Give it two — the right two, at the same time — and it does something more interesting. Preclinical models put the combined growth-hormone pulse from CJC-1295 No DAC + Ipamorelin at roughly 3 to 5 times baseline, versus about 1.5 to 2 times for either peptide on its own (Spartan Peptides research guide, 2026). That’s the entire reason this pairing has become the most-studied secretagogue stack in growth-hormone research.

The CJC-1295 No DAC 5mg + Ipamorelin 5mg Blend puts both peptides in one lyophilized vial at a clean 1:1 ratio — 10mg total. One reconstitution, two complementary pathways, no juggling separate vials or mismatched timing. Let me show you why the combination works, why the no-DAC form is the correct half of it, and where to buy it.

Before we go further: this is a research compound for in-vitro and laboratory use by qualified professionals. Neither peptide is approved for human use, and nothing here is a dosing protocol or clinical claim — it’s a description of what the research literature reports.

---

Two Peptides, Two Receptors, One Bigger Pulse

The synergy isn’t hand-waving — it’s mechanical, and it comes down to the two peptides hitting different doors on the same cell.

CJC-1295 No DAC (Modified GRF 1-29) is a GHRH analog. It binds the GHRH receptor and tells the pituitary to produce and prepare growth hormone. Ipamorelin is a selective ghrelin mimetic — a GHS-R agonist that tells the pituitary to release it, while amplifying the size of the pulse (Particle Peptides research summary, 2026). One primes the pump; the other opens the valve.

When researchers expose pituitary cells to both simultaneously, they observe greater GH release from the secretory granule pool than with either compound alone. Two pathways, converging on one output — that’s what “synergistic” actually means here, rather than just “additive.”

---

Why No-DAC, Not DAC, for This Stack?

This is the question that separates people who understand the stack from people who copied it. The answer matters, so here it is plainly.

The DAC (Drug Affinity Complex) version of CJC-1295 binds albumin and produces a sustained elevation lasting days — a steady “bleed” of GHRH signal. That’s excellent for some research, but it pairs poorly with Ipamorelin, which is built around acute, pulsatile release. Match a continuous signal with a pulse-timed one and you blur the very thing you’re trying to observe.

The no-DAC form (Mod GRF 1-29) has a half-life of roughly 30 minutes — short, sharp, and pulse-like, closely mirroring the body’s own GHRH rhythm (PeptIQ stack guide, 2026). Pair that with Ipamorelin and the two pulses line up. You also sidestep the receptor desensitization that chronic, non-pulsatile stimulation can invite. So when a protocol calls for physiologically-timed GH events, the no-DAC form isn’t a preference — it’s the correct tool.

---

Meet the Two Halves

A note on Ipamorelin’s pedigree: it was characterized as the first selective growth hormone secretagogue by Raun and colleagues in 1998, notable precisely because it drives GH release without the off-target cortisol and prolactin spikes seen with older GHRPs (Spartan Peptides, 2026). Clean signal, minimal noise, which is exactly what you want in a research tool.

---

Where This Blend Fits in the Lab

Researchers reach for the 1:1 stack when the question is about coordinated GH signaling:

---

Specifications and Quality Control

Every batch is held to the same bar: 99%+ purity on each component confirmed by HPLC and Mass Spectrometry, advanced lyophilization to stabilize both peptide chains, an exact 1:1 milligram distribution, and a batch-specific Certificate of Analysis (COA) with every shipment. Two peptides in one vial means two identities to verify — and the COA covers both.

---

Handling It in the Lab

Reconstituting a blend is no harder than a single peptide — both dissolve in the same solvent — but the usual peptide care applies. Bring the sealed vial to room temperature first, then add bacteriostatic or sterile water slowly against the inner glass wall rather than straight onto the powder. Swirl it gently; shaking is what shears delicate peptide bonds. Once it’s clear, split it into single-use aliquots so you’re not thawing and refreezing the whole vial every session.

Keep the powder frozen at -20°C, sealed away from light and moisture. Reconstituted, it lives at 2–8°C, shielded from light, good for a few weeks. If a solution ever looks hazy or off-color, retire it — a compromised blend isn’t worth a compromised dataset.

---

This Blend vs the Alternatives

The clean takeaway: the no-DAC-plus-Ipamorelin pairing exists because the timing fits. Swap in the DAC version and you lose the synchronization that makes the stack worth studying.

---

CJC-1295 No DAC + Ipamorelin Blend for Sale — Shipping Worldwide

Our research-grade CJC-1295 No DAC 5mg + Ipamorelin 5mg Blend ships as HPLC/MS-verified, COA-backed lyophilized vials, sealed and bench-ready. We fulfill orders for laboratories and independent researchers across the highest-demand markets:

• 🇺🇸 USA — fast domestic dispatch
• 🇨🇦 Canada — reliable cross-border delivery
• 🇩🇪 Germany (Deutschland) — trusted EU logistics
• 🇫🇷 France — secure European shipping
• Global Shipping

When you buy the CJC-1295 No DAC + Ipamorelin Blend from GLP1 Peptides, the pre-mixed 1:1 format saves you the fiddly work of co-reconstituting two peptides at matched concentrations — and the dual COA means you can trust both halves before the first assay.

---

FAQs about CJC-1295 No DAC + Ipamorelin Blend

1. What is the CJC-1295 No DAC 5mg + Ipamorelin 5mg Blend? A single lyophilized vial holding 5mg of CJC-1295 No DAC (Mod GRF 1-29) and 5mg of Ipamorelin in a 1:1 ratio — 10mg total — for growth-hormone secretagogue research.

2. How do the two peptides work together? CJC-1295 No DAC activates the GHRH receptor to prime GH production; Ipamorelin activates the ghrelin (GHS) receptor to trigger and amplify its release. Two pathways, one larger pulse.

3. Why no-DAC instead of DAC in this blend? Because Ipamorelin works through acute, pulsatile release, and the no-DAC form’s ~30-minute half-life matches that rhythm. The DAC version’s multi-day “bleed” would blur the pulse timing.

4. How much bigger is the combined effect? Preclinical models show combined GH pulses around 3–5× baseline versus 1.5–2× for either peptide alone, though results vary by dose, timing, and model.

5. What is Ipamorelin? A selective pentapeptide ghrelin mimetic and GHS-R agonist, characterized by Raun et al. in 1998 as the first selective GH secretagogue — it drives GH release with minimal cortisol or prolactin spillover.

6. What is CJC-1295 No DAC (Mod GRF 1-29)? A stabilized 29-amino-acid GHRH analog with four substitutions for enzyme resistance and a short, pulse-like ~30-minute half-life.

7. Are these peptides FDA approved? No. Both are investigational and supplied for laboratory research only; CJC-1295 is classified as an FDA 503A Category 2 substance and barred from compounding.

8. Are they banned in sport? Yes. Both fall under WADA’s S2 category (peptide hormones and growth factors), prohibited in and out of competition.

9. How should the blend be stored? Powder at -20°C, sealed and dark; reconstituted solution at 2–8°C, out of the light, used within a few weeks. Avoid freeze-thaw cycles.

10. How do you reconstitute a two-peptide blend? Exactly like one peptide — room-temperature vial, bacteriostatic or sterile water down the glass wall, gentle swirl, then aliquot. Both peptides share the same solvent.

11. Is the synergy guaranteed in every experiment? No. The literature generally supports a supra-additive response, but it depends on dose, timing, and species, and animal data doesn’t reliably predict human effects.

12. Where can I buy the CJC-1295 No DAC + Ipamorelin Blend internationally? GLP1 Peptides ships the research-grade, COA-verified blend to the USA, Canada, Germany, and France in sealed lyophilized vials. See the shipping section above.